Brief: Fortress Biotech Inc says On Oct 24 Was Notified By Nasdaq That Co Has Evidenced Compliance With $1.00 Bid Price Requirement For Continued Listing
26/10/2023 23:17
Oct 26 (Reuters) - Fortress Biotech Inc FBIO.O :
* FORTRESS BIOTECH INC - ON OCT 24 WAS NOTIFIED BY NASDAQ
THAT CO
HAS EVIDENCED COMPLIANCE WITH $1.00 BID PRICE REQUIREMENT FOR
CONTINUED LISTING
Further company coverage: FBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi